Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison (2022-07)

MADISON Total Knee Prosthesis is intended to be used for total knee arthroplasty to reduce pain and restore joint mobility of the knee.

Clinical data for MADISON Total Knee Prosthesis available are not deemed sufficient to support performance and benefits claimed on the whole lifetime of the product.

Thus, in order to maintain compliance with the EU regulation (2017/745) related to medical devices and following ISO 14/155:2020, SERF has set up post-market clinical follow-up study (PMCF) to confirm safety and performance of Total Knee Arthroplasty system MADISON. This study is designed to cover the expected 15-years follow-up, to retrieve data according to implant feature (Posterior Stabilized or Ultra Congruent) or fixation method and to gather data related to the revision of partial knee prosthesis.

The primary objective of this study is to assess the clinical safety of MADISON total knee prostheses. The secondary objective is to evaluate the survival rates, the clinical performances and clinical benefits of MADISON total knee prosthesis.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Clinical Department
  • Phone Number: +33 04 72 05 60 10
  • Email: clinical@serf.fr

Study Locations

    • Rhône
      • Lyon, Rhône, France, 69009
        • Recruiting
        • Clinique de la Sauvegarde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult subjects with a diagnosis of knee replacement surgery requiring to be implanted with a TKA (Total Knee Arthroplasty) system MADISON according to instructions for use. Patients will be followed according to current practice.

Description

Inclusion Criteria:

  • Male or female adults (≥ 18 years) covered by French social security system
  • Diagnosed with:

    • Osteoarthritis (primary and secondary),
    • Revision of a unicompartmental knee prosthesis.
  • Patient requiring a surgery and implantation of a Madison TKA (Total Knee Arthroplasty)
  • Patient physically and mentally able to comply with protocol, meet the follow-up visits as deemed by the investigator and fill in quality of life questionnaire.
  • Patient having signed a written informed consent

Exclusion Criteria:

  • Progressive, acute or chronic infection, local to the operative site or systemic that may affect the prosthetic joint,
  • Any loss of musculature or serious lesions of muscles, nerves and/or blood vessels deficiency, putting the affected limb at risk,
  • Lack of bone substance or inadequate bone quality on femoral or tibial surfaces, as it might compromise the stability of the prosthesis components,
  • Skeletal immaturity,
  • Pathologies that may compromise the functionality of the implant in any way (i.e. osteomyelitis, neuropathic joint),
  • Parameters incompatible with satisfactory long-term results (i.e. age, weight,
  • Neurological condition of the patient incompatible with the post-operative constraints associated with this type of intervention,
  • Known allergy to one of the implant components.
  • Severe obesity with or without comorbidities
  • Pregnant or nursing women,
  • Patients with a contraindication to radiography
  • Patients deprived of their liberty or hospitalised without their consent
  • Patients under legal protection (e.g. guardianship)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Revision rate according to Kaplan-Meier
Time Frame: 15 years
Assess the revision rate, whatever the cause of revision, including infection at 15 years
15 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival rate according to Kaplan-Meier
Time Frame: From per operative period to 15 years
Assess the survival rate, whatever the cause of revision, including infection at 1 year, 3 years, 5 years and 10 years follow-up
From per operative period to 15 years
Adverse events
Time Frame: From per operative period to 15 years
List type and occurence of adverse events
From per operative period to 15 years
Functional improvement using 2011KSS score
Time Frame: From per operative period to 15 years
2011 KSS stands for Knee Society Score Assessement of functional improvement picked up from global 2011KSS score. The functional score is composed of four subgroups and is rating from 0 to 100 (higher score means a better outcome).
From per operative period to 15 years
Patient's expectation / satisfaction using 2011KSS score
Time Frame: From per operative period to 15 years

2011 KSS stands for Knee Society Score Evaluation of patient's expectation / satisfaction is picked up from global 2011KSS score.

This evaluation is rating from 0 to 55 (higher score means a better outcome).

From per operative period to 15 years
Pain reduction using 2011KSS score
Time Frame: From per operative period to 15 years

2011 KSS stands for Knee Society Score Pain reduction evaluation is picked up from the symptom score of global 2011KSS score.

This score is rating from 0 to 25 (higher score means a better outcome).

From per operative period to 15 years
Pain Evaluation using KOOS
Time Frame: From per operative period to 15 years

Evaluate pain using KOOS score. KOOS stands for Knee Injury and Osteoarthritis Outcome Score. The questionnaire has five separately scored subscales: Pain, Function in Daily Living (ADL), Function in Sport and Recreation, Other Symptoms, and Knee-Related Quality of Life (QOL).

Pain evaluation is picked up from global KOOS score. Each question is assigned a score (0-4) and a normalized score is calculated for each subscale (100 indicates no symptoms and 0 indicates extreme symptoms)

From per operative period to 15 years
Functional improvement in Daily Living using KOOS
Time Frame: From per operative period to 15 years

Evaluate Function in Daily Living (ADL) using KOOS score. KOOS stands for Knee Injury and Osteoarthritis Outcome Score. The questionnaire has five separately scored subscales: Pain, Function in Daily Living (ADL), Function in Sport and Recreation, Other Symptoms, and Knee-Related Quality of Life (QOL).

Function in Daily Living (ADL) evaluation is picked up from global KOOS score. Each question is assigned a score (0-4) and a normalized score is calculated for each subscale (100 indicates no symptoms and 0 indicates extreme symptoms)

From per operative period to 15 years
Functional improvement in Sport and Recreation using KOOS
Time Frame: From per operative period to 15 years

Evaluate Function in Sport and Recreation using KOOS score. KOOS stands for Knee Injury and Osteoarthritis Outcome Score. The questionnaire has five separately scored subscales: Pain, Function in Daily Living (ADL), Function in Sport and Recreation, Other Symptoms, and Knee-Related Quality of Life (QOL).

Function in Sport and Recreation evaluation is picked up from global KOOS score.

Each question is assigned a score (0-4) and a normalized score is calculated for each subscale (100 indicates no symptoms and 0 indicates extreme symptoms)

From per operative period to 15 years
Functional improvement Other Symptoms using KOOS
Time Frame: From per operative period to 15 years

Evaluate Other Symptoms using KOOS score. KOOS stands for Knee Injury and Osteoarthritis Outcome Score. The questionnaire has five separately scored subscales: Pain, Function in Daily Living (ADL), Function in Sport and Recreation, Other Symptoms, and Knee-Related Quality of Life (QOL).

Other Symptoms evaluation is picked up from global KOOS score. Each question is assigned a score (0-4) and a normalized score is calculated for each subscale (100 indicates no symptoms and 0 indicates extreme symptoms)

From per operative period to 15 years
Assessement of Knee-Related Quality of Life using KOOS
Time Frame: From per operative period to 15 years

Evaluate Knee-Related Quality of Life (QOL) using KOOS score. KOOS stands for Knee Injury and Osteoarthritis Outcome Score. The questionnaire has five separately scored subscales: Pain, Function in Daily Living (ADL), Function in Sport and Recreation, Other Symptoms, and Knee-Related Quality of Life (QOL).

Knee-Related Quality of Life (QOL) assessement is picked up from global KOOS score.

Each question is assigned a score (0-4) and a normalized score is calculated for each subscale (100 indicates no symptoms and 0 indicates extreme symptoms)

From per operative period to 15 years
Oblivion of prosthesis
Time Frame: From per operative period to 15 years

Assess the degree of forgetfulness of the prosthesis using FJS-score (Forgotten Joint Score):

FJS stands for Forgotten Joint Score. The Forgotten Joint Score assessement consists of 12 questions and is scored on a 0-100 scale. The higher is the score, the less the patient is aware of their affected joint when performing daily activities.

From per operative period to 15 years
Mobility improvement
Time Frame: From per operative period to 15 years
Assessed by the surgeon through questionary with a 4 item-scale : significant improvement / slight improvement / identical mobility / decrease of mobility
From per operative period to 15 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 17, 2023

Primary Completion (Estimated)

December 31, 2040

Study Completion (Estimated)

December 31, 2040

Study Registration Dates

First Submitted

October 18, 2023

First Submitted That Met QC Criteria

November 6, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 6, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-07_Madison3

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthropathy

3
Subscribe